Register for our free email digests:
Agency for Science, Technology, and Research
Latest From Tapestry Pharmaceuticals Inc.
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
Dr Gilles Tapolsky has joined Advanced Cancer Therapeutics (US) as chief scientific officer. He has more than 20 years' experience in corporate management, research and pharmaceutical development, having previously served as vice-president of product development at Tapestry Pharmaceuticals.
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.